Skip to main content

Moderna's first-quarter profit triples on vaccine sales

Moderna said Wednesday that revenue from its COVID-19 vaccine sales helped the company to triple its net income in a better-than-expected first quarter.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.